Drug intelligence / Profile preview

canna edulis RS3 resistant starch

Development stage
Unknown
Lead developer
Yilitai Technology
Modality
Microbiome Therapeutics
Administration
Oral
01

Overview

Canna edulis RS3 resistant starch (Ce-RS3) is a type 3 resistant starch derived from the rhizomes of the plant Canna edulis. It is an insoluble dietary fiber with high resistance to enzymatic digestion and notable prebiotic properties. Ce-RS3 has been shown in animal and human studies to improve blood lipid profiles by lowering total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol. It also modulates gut microbiota composition—enriching beneficial bacteria such as Faecalibacterium, Agathobacter, Bifidobacterium, and Roseburia—and increases short-chain fatty acid production through fermentation in the colon[1][2][4]. Ce-RS3 demonstrates anti-obesity effects by reducing weight gain and metabolic inflammation in animal models[4]. Additionally, it has shown potential neuroprotective effects in Parkinson’s disease models by reducing neuroinflammation and neuronal apoptosis[6]. Its mechanism of action involves acting as a prebiotic dietary fiber that alters host-microbiota interactions to regulate lipid metabolism, reduce systemic inflammation, support antioxidant activity (e.g., increasing glutathione peroxidase), and influence amino acid/lipid metabolism pathways[1][2][4][6].

Other names
Ce-RS3Ce-RS-3Ce-RS 3type 3 resistant starch from Canna edulistype3 resistant starch from Canna edulistype-3 resistant starch from Canna edulisCanna edulis RS3-resistant starch

Beyond the preview

Go deeper on canna edulis RS3 resistant starch.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on canna edulis RS3 resistant starch.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call